Showing results (1341-1350 of 2,107) with videos related to
Sort By:
Pageof 211
CNS Drugs|September 11, 2009
Spotlight on buprenorphine/naloxone in the treatment of opioid dependenceJennifer S Orman, Gillian M KeatingCNS Drugs|November 13, 2008
The role of phosphodiesterases in schizophrenia : therapeutic implicationsJudith A SiuciakCNS Drugs|November 13, 2008
Hypnosedative-induced complex behaviours : incidence, mechanisms and managementChristian R Dolder, Michael H NelsonCNS Drugs|August 16, 2005
The opioidergic-alcohol link : implications for treatmentVania Modesto-Lowe, Eleanor M FritzCNS Drugs|September 28, 2005
COX-2 inhibitors as adjunctive therapy in schizophrenia: rationale for use and evidence to dateMichael Riedel, Martin Strassnig, Markus J Schwarz, et al.CNS Drugs|September 28, 2005
Progress in the identification of stroke-related genes: emerging new possibilities to develop concepts in stroke therapyAndrea Lippoldt, Andreas Reichel, Ursula MoenningCNS Drugs|September 28, 2005
Augmentation strategies in clozapine-resistant schizophreniaGary Remington, Amitabha Saha, Siow-Ann Chong, et al.CNS Drugs|September 28, 2005
Recent advances in the development of treatments for alcohol and cocaine dependence: focus on topiramate and other modulators of GABA or glutamate functionBankole A JohnsonCNS Drugs|February 8, 2007
Treatment strategies after a single seizure : rationale for immediate versus deferred treatmentLaura C Miller, Frank W DrislaneCNS Drugs|February 8, 2007
Spectral frequency index monitoring during propofol-remifentanil and propofol-alfentanil total intravenous anaesthesiaZbigniew Zaba, Agnieszka Bienert, Leon Drobnik, et al.Pageof 211